arrow
S

Szymon Skoczeń

jagiellonian university medical college
H指数:15
被引数:1,018

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment Outcomes and Prognostic Factors in Children with Myeloid Leukemia Associated with Down Syndrome: A Nationwide Polish Retrospective Study

唐氏综合征相关髓系白血病患儿的疗效及预后因素:一项全国性波兰回顾性研究

2026-09-290
OA
Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta

神经母细胞瘤患者在接受替莫唑胺、伊立替康和地努珠单抗β化疗免疫治疗后,自体干细胞移植治疗的静脉闭塞病发生率

Cancers
IF4.4
2026-09-090
OA
Retrospective Multicenter Study on Childhood Kaposiform Hemangioendothelioma (2007-2024): Report of the Section of Childhood Vascular Anomalies of the Polish Society of Pediatric Oncology and Hematology

回顾性多中心研究:儿童卡波西样血管内皮瘤(2007-2024)(波兰儿科肿瘤学和血液学会儿童血管畸形分会的报告)

2025-12-011
PRE
Evacuating Patients With Pediatric Cancer From Ukraine: Impact on Medical Care Capacity in Poland
2025-02-010
OAAI
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

儿童 γ δ t-all的生物学和临床分析将LMO2/STAG2重排确定为极高风险

2024-06-242
PRE
Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cilgavimab for COVID-19 among Immunocompromised Pediatric Patients

暴露前预防和使用Tixagevimab/Cilgavimab治疗免疫功能低下的儿科患者的新型冠状病毒肺炎

2024-03-310
OAAI
Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience

Gemtuzumab ozogamicin治疗儿童复发或原发性难治性急性髓系白血病-波兰儿童白血病和淋巴瘤研究组经验

2023-12-222
OAAI
Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group
2022-06-254
OAAI